The 36-month beta value for VXRT is also noteworthy at 0.59. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for VXRT is 171.50M, and at present, short sellers hold a 9.10% of that float. The average trading volume of VXRT on April 09, 2024 was 2.15M shares.
VXRT) stock’s latest price update
Vaxart Inc (NASDAQ: VXRT)’s stock price has plunge by -4.17relation to previous closing price of 1.08. Nevertheless, the company has seen a -16.53% plunge in its stock price over the last five trading sessions. GlobeNewsWire reported 2024-03-27 that SOUTH SAN FRANCISCO, Calif., March 27, 2024 (GLOBE NEWSWIRE) — Vaxart, Inc. (Nasdaq: VXRT) today announced that Dr. Sean Tucker, Founder and Chief Scientific Officer, will present at the World Vaccine Congress Washington 2024 in Washington, D.C. on Wednesday, April 3, 2024. The Company has appeared repeatedly at the annual event in Washington, D.C.
VXRT’s Market Performance
VXRT’s stock has fallen by -16.53% in the past week, with a monthly drop of -13.03% and a quarterly rise of 81.32%. The volatility ratio for the week is 11.42% while the volatility levels for the last 30 days are 8.44% for Vaxart Inc The simple moving average for the last 20 days is -12.84% for VXRT stock, with a simple moving average of 23.23% for the last 200 days.
Analysts’ Opinion of VXRT
Many brokerage firms have already submitted their reports for VXRT stocks, with Jefferies repeating the rating for VXRT by listing it as a “Buy.” The predicted price for VXRT in the upcoming period, according to Jefferies is $12 based on the research report published on December 29, 2021 of the previous year 2021.
Cantor Fitzgerald, on the other hand, stated in their research note that they expect to see VXRT reach a price target of $15. The rating they have provided for VXRT stocks is “Overweight” according to the report published on November 02nd, 2021.
B. Riley Securities gave a rating of “Neutral” to VXRT, setting the target price at $9 in the report published on June 29th of the previous year.
VXRT Trading at -13.03% from the 50-Day Moving Average
After a stumble in the market that brought VXRT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -34.91% of loss for the given period.
Volatility was left at 8.44%, however, over the last 30 days, the volatility rate increased by 11.42%, as shares sank -10.43% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +17.85% upper at present.
During the last 5 trading sessions, VXRT fell by -16.94%, which changed the moving average for the period of 200-days by +6.59% in comparison to the 20-day moving average, which settled at $1.1815. In addition, Vaxart Inc saw 80.69% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for VXRT
Current profitability levels for the company are sitting at:
- -14.56 for the present operating margin
- 0.2 for the gross margin
The net margin for Vaxart Inc stands at -14.41. The total capital return value is set at -1.07. Equity return is now at value -97.94, with -67.13 for asset returns.
Based on Vaxart Inc (VXRT), the company’s capital structure generated 0.14 points at debt to capital in total, while cash flow to debt ratio is standing at -7.72. The debt to equity ratio resting at 0.16. The interest coverage ratio of the stock is -57.6.
Currently, EBITDA for the company is -78.85 million with net debt to EBITDA at 0.11. When we switch over and look at the enterprise to sales, we see a ratio of 30.15. The receivables turnover for the company is 1.9for trailing twelve months and the total asset turnover is 0.06. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.32.
Conclusion
In summary, Vaxart Inc (VXRT) has had a mixed performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
